ARCHIVES

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Obituary: Gregory Foltz, Swedish Medical Center Neurosurgeon

July 12, 2013

ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies

May 2, 2003

ASCO Urges Increase In Research Funding, Removal of Barriers For Trial Participation

January 23, 2009

President’s Budget Would Permit NCI Funding Of Only 23.2% Of Approved Traditional Grants

January 26, 1979

Science Policy: NI DOD Begins Project For Common Coding Of Cancer Grants

April 2, 1999

NCI document says 2015 goal formed in 2001, long before announcement.

February 13, 2004